檢索結果 - Vicky Roy
- Showing 1 - 6 results of 6
-
1
Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination 由 Vicky Roy, Wonyeong Jung, Caitlyn Linde, Emily Coates, Julie Ledgerwood, Pamela Costner, Galina Yamshchikov, Hendrik Streeck, Boris Juelg, Douglas A. Lauffenburger, Galit Alter
發表在 npj Vaccines (2023-03-01)獲取全文
Article -
2
Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue disease 由 Antonio G. Dias, Jr., Elias M. Duarte, Jose Victor Zambrana, Jaime A. Cardona-Ospina, Sandra Bos, Vicky Roy, Julia Huffaker, Guillermina Kuan, Angel Balmaseda, Galit Alter, Eva Harris
發表在 Cell Reports (2025-05-01)獲取全文
Article -
3
Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using FcγRIIIa affinity chromatography 由 Julie M. Fox, Julie M. Fox, Vicky Roy, Bronwyn M. Gunn, Glen R. Bolton, Daved H. Fremont, Daved H. Fremont, Galit Alter, Galit Alter, Michael S. Diamond, Michael S. Diamond, Michael S. Diamond, Austin W. Boesch
發表在 Frontiers in Immunology (2023-05-01)獲取全文
Article -
4
Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern 由 Ryan P. McNamara, Jenny S. Maron, Julie Boucau, Vicky Roy, Nicholas E. Webb, Harry L. Bertera, Amy K. Barczak, The Positives Study Staff, Nicholas Franko, Jennifer K. Logue, Megan Kemp, Jonathan Z. Li, Ling Zhou, Ching-Lin Hsieh, Jason S. McLellan, Mark J. Siedner, Michael S. Seaman, Jacob E. Lemieux, Helen Y. Chu, Galit Alter
發表在 mBio (2023-08-01)獲取全文
Article -
5
Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2 由 Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, Sebastian Ols, Daniel J. Sheward, Changil Kim, Alberto Cagigi, Matthew Gagne, Brandon Davis, Daritza Germosen, Vicky Roy, Galit Alter, Hélène Letscher, Jérôme Van Wassenhove, Wesley Gros, Anne-Sophie Gallouët, Roger Le Grand, Harry Kleanthous, Mimi Guebre-Xabier, Ben Murrell, Nita Patel, Gregory Glenn, Gale Smith, Karin Loré
發表在 npj Vaccines (2024-01-01)獲取全文
Article -
6
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsResearch in context 由 Christopher L. Cooper, Gavin Morrow, Maoli Yuan, Thomas S. Postler, Maxwell L. Neal, Robert W. Cross, Courtney Woolsey, Krystle N. Agans, Viktoriya Borisevich, Ryan P. McNamara, Caroline Atyeo, Vicky Roy, Daritza Germosen, Fuxiang Hou, Shui L. Li, Lucia Reiserova, Yesle Choi, Aaron Wilson, Denise Wagner, Olivia Wallace-Selman, Alexei Carpov, Fuqiang Geng, Deborah J. Frederick, Joanne DeStefano, Anne M. Ercolini, Adrian S. Enriquez, Kathryn M. Hastie, Suzane Ramos da Silva, Eddy Sayeed, John W. Coleman, Andrew Kilianski, Galit Alter, Erica Ollmann Saphire, John D. Aitchison, Thomas W. Geisbert, Swati B. Gupta, Mark B. Feinberg, Christopher L. Parks
發表在 EBioMedicine (2025-04-01)獲取全文
Article
